L’index FIB-4 pour faire le diagnostic de fibrose hépatique avancée au cours de la stéatose hépatique = FIB-4 index to rule-out advanced liver fibrosis in NAFLD patients
The FIB-4 index is a biomarker of advanced hepatic fibrosis in a context of fatty liver disease.
The calculation of the FIB-4 index requires of age, serum ALT and AST transaminase levels and platelet count.
A FIB-4 index < 1.45 in a context of fatty liver disease excludes clinically significant hepatic fibrosis.
Additional explorations are mandatory to excluded hepatic fibrosis for a a FIB-4 index > 1.45 in a context of fatty liver disease.
A complete hepatological workup is mafatory for a FIB-4 index > 3.25 in a context of fatty liver disease
